Archives of Toxicology

, Volume 86, Issue 4, pp 521–534 | Cite as

Zinc and human health: an update

  • Christos T. Chasapis
  • Ariadni C. Loutsidou
  • Chara A. Spiliopoulou
  • Maria E. Stefanidou
Review Article

Abstract

The importance of micronutrients in health and nutrition is undisputable, and among them, zinc is an essential element whose significance to health is increasingly appreciated and whose deficiency may play an important role in the appearance of diseases. Zinc is one of the most important trace elements in the organism, with three major biological roles, as catalyst, structural, and regulatory ion. Zinc-binding motifs are found in many proteins encoded by the human genome physiologically, and free zinc is mainly regulated at the single-cell level. Zinc has critical effect in homeostasis, in immune function, in oxidative stress, in apoptosis, and in aging, and significant disorders of great public health interest are associated with zinc deficiency. In many chronic diseases, including atherosclerosis, several malignancies, neurological disorders, autoimmune diseases, aging, age-related degenerative diseases, and Wilson’s disease, the concurrent zinc deficiency may complicate the clinical features, affect adversely immunological status, increase oxidative stress, and lead to the generation of inflammatory cytokines. In these diseases, oxidative stress and chronic inflammation may play important causative roles. It is therefore important that status of zinc is assessed in any case and zinc deficiency is corrected, since the unique properties of zinc may have significant therapeutic benefits in these diseases. In the present paper, we review the zinc as a multipurpose trace element, its biological role in homeostasis, proliferation and apoptosis and its role in immunity and in chronic diseases, such as cancer, diabetes, depression, Wilson’s disease, Alzheimer’s disease, and other age-related diseases.

Keywords

Zinc Health Zinc biology Metallothioneins Oxidative stress Apoptosis Immune response 

References

  1. Adamo AM, Zago MP, Mackenzie GG, Aimo L, Keen CL, Keenan A, Oteiza PI (2010) The role of zinc in the modulation of neuronal proliferation and apoptosis. Neurotoxic Res 17:1–14Google Scholar
  2. Adlard PA, Parncutt JM, Finkelstein DI, Bush AI (2010) Cognitive loss in zinc transporter-3 knock-out mice: a phenocopy for the synaptic and memory deficits of Alzheimer’s disease? J Neurosci 30:1631–1636PubMedGoogle Scholar
  3. Albrecht AL, Somji S, Sens MA, Sens DA, Garrett SH (2008) Zinc transporter mRNA expression in the RWPE-1 human prostate epithelial cell line. Biometals 4:405–416Google Scholar
  4. Amani R, Saeidi S, Nazari Z, Nematpour S (2010) Correlation between dietary zinc intakes and its serum levels with depression scales in young female students. Biol Trace Elem Res 137(2):150–158PubMedGoogle Scholar
  5. Ando A, Kikuti YY, Shigenari A et al (1996) cDNA cloning of the human homologues of the mouse Ke4 and Ke6 genes at the centromeric end of the human MHC region. Genomics 35:600–602PubMedGoogle Scholar
  6. Aschner M (1996) The functional significance of brain. Metallothionein. FASEB J 10:1129–1136PubMedGoogle Scholar
  7. Atwood CS, Huang X, Moir RD, Tanzi RE, Bush AI (1999) Role of free radicals and metal ions in the pathogenesis of Alzheimer’s disease. Met Ions Biol Syst 36:309–364PubMedGoogle Scholar
  8. Bao B, Prasad AS, Beck FW, Godmere M (2003) Zinc modulates mRNA levels of cytokines. Am J Physiol Endocrinol Metab 285:E1095–E1102PubMedGoogle Scholar
  9. Bao B, Prasad AS, Beck FW, Fitzgerald JT, Snell D, Bao GW, Singh T, Cardozo LJ (2010) Zinc decreases C-reactive protein, lipid peroxidation, and inflammatory cytokines in elderly subjects: a potential implication of zinc as an atheroprotective agent. Am J Clin Nutr 91(6):1634–1641PubMedGoogle Scholar
  10. Barceloux DG (1999) Zinc. Clin Toxicol 37:279–292Google Scholar
  11. Barnham KJ, Bush AI (2008) Metals in Alzheimer’s and Parkinson’s diseases. Curr Opin Chem Biol 12:222–228PubMedGoogle Scholar
  12. Beck FW, Prasad AS, Kaplan J, Fitzgerald JT, Brewer GJ (1997) Changes in cytokine production and T cell subpopulations in experimentally induced zinc-deficient humans. Am J Physiol 272:E1002–E1007PubMedGoogle Scholar
  13. Beharier O, Etzion Y, Katz A, Friedman H, Tenbosh N, Zacharish S et al (2007) Crosstalk between L-type calcium channels and ZnT-1, a new player in rate-dependent cardiac electrical remodeling. Cell Calcium 42:71–82PubMedGoogle Scholar
  14. Beyersmann D (2002) Homeostasis and cellular functions of zinc. Mat Wiss U Werkstofftech 33:764–769Google Scholar
  15. Bhowmik D, Chiranjib KP, Kumar KPS (2010) A potential medicinal importance of zinc in human health and chronic disease. Int J Pharm Biomed Sci 1(1):05–11Google Scholar
  16. Bravou V, Antonacopoulou A, Papadaki H, Floratou K, Stavropoulos M, Episkopou V, Petropoulou C, Kalofonos H (2009) TGF-beta repressors SnoN and Ski are implicated in human colorectal carcinogenesis. Cell Oncol 31(1):41–51PubMedGoogle Scholar
  17. Bruinsma JJ, Jirakulaporn T, Muslin AJ, Kornfeld K (2002) Zinc ions and cation diffusion facilitator proteins regulate Ras-mediated signaling. Dev Cell 2:567–578PubMedGoogle Scholar
  18. Brzovic PS, Rajagopal P, Hoyt DW, King MC, Klevit RE (2001) Structure of a BRCA1-BARD1 heterodimeric RING–RING complex. Nat Struct Biol 10:833–837Google Scholar
  19. Brzovic PS, Keeffe JR, Nishikawa H, Miyamoto K, Fox D III, Fukuda M et al (2003) Binding and recognition in the assembly of an active BRCA1/BARD1 ubiquitin-ligase complex. Proc Natl Acad Sci USA 100:5646–5651PubMedGoogle Scholar
  20. Büntzel J, Bruns F, Glatzel M, Garayev A, Mücke R, Kisters K, Schäfer U, Schönekaes K, Micke O (2007) Zinc concentrations in serum during head and neck cancer progression. Anticancer Res 27(4A):1941–1943PubMedGoogle Scholar
  21. Bush AI (2000) Metals and neuroscience. Curr Opin Chem Biol 4:184–191PubMedGoogle Scholar
  22. Bush AI (2002) Metal complexing agents as therapies for Alzheimer’s disease. Neurobiol Aging 23:1031–1038PubMedGoogle Scholar
  23. Bush AI, Tanzi RE (2008) Therapeutics for Alzheimer’s disease based on the metal hypothesis. Neurotherapeutics 5(3):421–432PubMedGoogle Scholar
  24. Bussereau F, Lafay JF, Bolotin-Fukuhara M (2004) Zinc finger transcriptional activators of yeasts. FEMS Yeast Res 4(4–5):445–458PubMedGoogle Scholar
  25. Calesnick B, Dinan AM (1988) Zinc deficiency and zinc toxicity. Am Fam Physician 37:267–270PubMedGoogle Scholar
  26. Carroll RJ, Hammer RE, Chan SJ, Swift HH, Rubenstein AH, Steiner DF (1988) A mutant human proinsulin is secreted from islets of Langerhans in increased amounts via an unregulated pathway. Proc Natl Acad Sci USA 85:8943–8947PubMedGoogle Scholar
  27. Chakravarty PK, Ghosh A, Chowdhury JR (1985) Zinc in human malignancies. Neoplasma 33:85–90Google Scholar
  28. Chasapis CT, Spyroulias GA (2009) Ring finger E3 ubiquitin ligases: structure and drug discovery. Curr Pharm Des 15–31:3716–3731Google Scholar
  29. Chasapis CT, Loutsidou AK, Orkoula MG and Spyroulias GA (2010) Zinc binding properties of engineered RING finger domain of Arkadia E3 ubiquitin ligase. Bioinorg Chem Appl vol 2010, Article ID 323152, p 7Google Scholar
  30. Cherny RA, Atwood CS, Xilinas ME, Gray DN, Jones WD et al (2001) Treatment with a copper-zinc chelator markedly and rapidly inhibits betaamyloid accumulation in Alzheimer’s disease transgenic mice. Neuron 30:665–676PubMedGoogle Scholar
  31. Chimienti F, Aouffen M, Favier A, Seve M (2003) Zinc homeostasis-regulating proteins: new drug targets for triggering cell fate. Curr Drug Targets 4:323–338PubMedGoogle Scholar
  32. Chimienti F, Devergnas S, Pattou F, Schuit F, Garcia-Cuenca R, Vandewalle B et al (2006) In vivo expression and functional characterization of the zinc transporter ZnT8 in glucose-induced insulin secretion. J Cell Sci 119:4199–4206PubMedGoogle Scholar
  33. Clegg MS, Hanna LA, Niles BJ, Momma TY, Keen CL (2005) Zinc deficiency-induced cell death. IUBMB Life 57:661–669PubMedGoogle Scholar
  34. Cohen N, Golik A (2006) Zinc balance and medications commonly used in the management of heart failure. Heart Fail Rev 11:19–24PubMedGoogle Scholar
  35. Cole TB, Wenzel HJ, Kafer KE, Schwartzkroin PA, Palmiter RD (1999) Elimination of zinc from synaptic vesicles in the intact mouse brain by disruption of the ZnT3 gene. Proc Natl Acad Sci USA 96:1716–1721PubMedGoogle Scholar
  36. Corniola RS, Tassabehji NM, Hare J, Sharma G, Levenson CW (2008) Zinc deficiency impairs neuronal precursor cell proliferation and induces apoptosis via p53-mediated mechanisms. Brain Res 1237:52–61PubMedGoogle Scholar
  37. Costello LC, Franklin RB (2006) The clinical relevance of the metabolism of prostate cancer; zinc and tumor suppression: connecting the dots. Mol Cancer 5:17PubMedGoogle Scholar
  38. Coyle P, Philcox JC, Carey LC, Rofe AM (2002) Metallothionein: the multipurpose protein. Cell Mol Life Sci 59:627–647PubMedGoogle Scholar
  39. Darling DS, Gaur NK, Zhu BA (1998) Zinc finger homeodomain transcription factor binds specific thyroid hormone response elements. Mol Cell Endocrinol 139:25–35PubMedGoogle Scholar
  40. Davis SR, McMahon RJ, Cousins RJ (1998) Metallothionein knockout and transgenic mice exhibit altered intestinal processing of zinc with uniform zinc-dependent zinc transporter-1expression. J Nutr 128:825–831PubMedGoogle Scholar
  41. DePasquale-Jardieu P, Fraker PJ (1980) Further characterization of the role of corticosterone in the loss of humoral immunity in zinc-deficient A/J mice as determined by adrenalectomy. J Immunol 124:2650–2655PubMedGoogle Scholar
  42. Dhawan DK, Chadha VD (2010) Zinc: a promising agent in dietary chemoprevention of cancer. Indian J Med Res 132(6):676–682PubMedGoogle Scholar
  43. Dodson G, Steiner D (1998) The role of assembly in insulin’s biosynthesis. Curr Opin Struct Biol 8:189–194PubMedGoogle Scholar
  44. Dong J, Atwood CS, Anderson VE, Siedlak SL, Smith MA et al (2003) Metal binding and oxidation of amyloid-beta within isolated senile plaque cores: Raman microscopic evidence. Biochemistry 42:2768–2773PubMedGoogle Scholar
  45. Dreosti IE (2001) Zinc and the gene. Mutat Res 475:161–167PubMedGoogle Scholar
  46. Eide DJ (2006) Zinc transporters and the cellular trafficking of zinc. Biochim Biophys Acta 1763(7):711–722PubMedGoogle Scholar
  47. Etzion Y, Ganiel A, Beharier O, Shalev A, Novack V, Volvich L et al (2008) Correlation between atrial ZnT-1 expression and atrial fibrillation in humans: a pilot study. J Cardiovasc Electrophysiol 19:157–164PubMedGoogle Scholar
  48. Fabris N, Mocchegiani E, Albertini G (1993) Psycoendocrine-immune interactions in Down’s syndrome: role of zinc. In: Castells S, Wisnieski KE (eds) Growth hormone treatment in Down’s syndrome. Wiley, New York, pp 203–218Google Scholar
  49. Fabris N, Mocchegiani E, Provinciali M (1997) Plasticity of neuroendocrine—thymus interactions during aging. Exp Gerontol 32:415–429PubMedGoogle Scholar
  50. Faller P (2009) Copper and zinc binding to amyloid-beta: coordination, dynamics, aggregation, reactivity and metal-ion transfer. Chembiochem 10(18):2837–2845PubMedGoogle Scholar
  51. Fernández-Gamba A, Leal MC, Morelli L, Castaño EM (2009) Insulin-degrading enzyme: structure-function relationship and its possible roles in health and disease. Curr Pharm Des 15(31):3644–3655PubMedGoogle Scholar
  52. Fraker PJ (2005) Roles for cell death in zinc deficiency. J Nutr 135:359–362PubMedGoogle Scholar
  53. Fraker PJ, King LE, Laakko T, Vollmer TL (2000) The dynamic link between the integrity of the immune system and zinc status. J Nutr 130(5S Suppl):1399S–1406SPubMedGoogle Scholar
  54. Freedman DA, Wu L, Levine AJ (1999) Functions of the MDM2 oncoprotein. Cell Mol Life Sci 55:96–107PubMedGoogle Scholar
  55. Friedlich AL, Lee JY, van Groen T, Cherny RA, Volitakis I et al (2004) Neuronal zinc exchange with the blood vessel wall promotes cerebral amyloid angiopathy in an animal model of Alzheimer’s disease. J Neurosci 24:3453–3459PubMedGoogle Scholar
  56. Giaccia AJ, Kastan MB (1998) The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev 12:2973–2983PubMedGoogle Scholar
  57. Gilmore TD (2006) Introduction to NF-kB: players, pathways, perspectives. Oncogene 25:6680–6684PubMedGoogle Scholar
  58. Golik A, Cohen N, Ramot Y, Maor J, Moses R, Weissgarten J et al (1993) Type II diabetes mellitus, congestive heart failure, and zinc metabolism. Biol Trace Elem Res 39:171–175PubMedGoogle Scholar
  59. Gupta SK, Singh SP, Shukla VK (2005) Copper, zinc, and Cu/Zn ratio in carcinoma of the gallbladder. J Surg Oncol 91:204–208PubMedGoogle Scholar
  60. Haase H, Maret W (2003) Intracellular zinc fluctuations modulate protein tyrosine phosphatase activity in insulin/insulin-like growth factor-1 signaling. Exp Cell Res 291:289–298PubMedGoogle Scholar
  61. Haase H, Rink L (2009) The immune system and the impact of zinc during aging. Immun Ageing 6:9PubMedGoogle Scholar
  62. Holt D, Magos L, Webb M (1980) The interaction of cadium-induced rat renal metallothionein with bivalent mercury in vitro. Chem Biol Interact 32(1–2):125–135PubMedGoogle Scholar
  63. Huster D (2010) Wilson disease. Best Pract Res Clin Gastroenterol 24(5):531–539PubMedGoogle Scholar
  64. Issell BF, Macfadyen BV, Gum ET, Valdivieso M, Dudrick SJ, Bodey GP (2006) Serum zinc levels in lung cancer patients. Cancer 47:1845–1848Google Scholar
  65. Joazeiro CA, Weissman AM (2000) RING finger proteins: mediators of ubiquitin ligase activity. Cell 102(5):549–552PubMedGoogle Scholar
  66. John E, Laskow TC, Buchser WJ, Pitt BR (2010) Zinc in innate and adaptive tumor immunity. J Transl Med 8:118PubMedGoogle Scholar
  67. Jomovaa K, Valko M (2011) Advances in metal-induced oxidative stress and human disease. Toxicology 283(2–3):65–87Google Scholar
  68. Kabu K, Yamasaki S, Kamimura D, Ito Y, Hasegawa A, Sato E, Kitamura H, Nishida K, Hirano T (2006) Zinc is required for Fc epsilon RI-mediated mast cell activation. J Immunol 177(2):1296–1305PubMedGoogle Scholar
  69. Kadrmas JL, Smith MA, Clark KA, Pronovost SM, Muster N, Yates JR III, Beckerle MC (2004) The integrin effector PINCH regulates JNK activity and epithelial migration in concert with Ras suppressor 1. J Cell Biol 167(6):1019–1024PubMedGoogle Scholar
  70. Kagara N, Tanaka N, Noguchi S, Hirano T (2007) Zinc and its transporter ZIP10 are involved in invasive behavior of breast cancer cells. Cancer Sci 98:692–697PubMedGoogle Scholar
  71. Kandias NG, Chasapis CT, Episkopou V, Bentrop D, Spyroulias GA (2009) High yield expression and NMR characterization of Arkadia E3 ubiquitin ligase RING-H2 finger domain. Biochem Biophys Res Commun 378:498–502PubMedGoogle Scholar
  72. Karagulova G, Yue Y, Moreyra A, Boutjdir M, Korichneva I (2007) Protective role of intracellular zinc in myocardial ischemia/reperfusion is associated with preservation of protein kinase C isoforms. J Pharmacol Exp Ther 321:517–525PubMedGoogle Scholar
  73. Katoh S, Hong C, Tsunoda Y, Murata K, Takai R, Minami E, Yamazaki T, Katoh E (2003) High precision NMR structure and function of the RING-H2 finger domain of EL5, a rice protein whose expression is increased upon exposure to pathogen-derived oligosaccharides. J Biol Chem 278:15341–15348PubMedGoogle Scholar
  74. Keen CL, Gershwin ME (1990) Zinc deficiency and immune function. Annu Rev Nutr 10:415–431PubMedGoogle Scholar
  75. Kelly EJ, Quaife CJ, Froelick GJ, Palmiter RD (1996) Metallothionein I and II protect against zinc deficiency and zinc toxicity in mice. J Nutr 126(7):1782–1790PubMedGoogle Scholar
  76. Kitamura H, Morikawa H, Kamon H, Iguchi M, Hojyo S, Fukada T, Yamashita S, Kaisho T, Akira S, Murakami M, Hirano T (2006) Toll-like receptormediated regulation of zinc homeostasis influences dendritic cell function. Nat Immunol 7:971–977PubMedGoogle Scholar
  77. Kondoh M, Imada N, Kamada K, Tsukahara R, Higashimoto M, Takiguchi M, Watanabe Y, Sato M (2003) Property of metallothionein as a Zn pool differs depending on the induced condition of metallothionein. Toxicol Lett 142(1–2):11–18PubMedGoogle Scholar
  78. Koropatnick J, Cherian MG (1993) A mutant mouse (tx) with increased hepatic metallothionein stability and accumulation. Biochem J 296(Pt 2):443–449PubMedGoogle Scholar
  79. Kovalovsky D, Uche OU, Eladad S, Hobbs RM, Yi W, Alonzo E, Chua K, Eidson M, Kim H-J, Im JS, Pandolfi PP, Sant’Angelo DB (2008) The BTB-zinc finger transcriptional regulator, PLZF, controls the development of iNKT cell effector functions. Nat Immunol 9:1055–1064PubMedGoogle Scholar
  80. Krezel A, Maret W (2007) Dual nanomolar and picomolar Zn(II) binding properties of metallothionein. J Am Chem Soc 129:10911–10921PubMedGoogle Scholar
  81. Kumar V, Cotran R, Robbins SL (2003) Cell injury, adaptation, and death. In: Robbins basic pathology, 7th edn. Saunders, An Imprint of Elsevier, PhiladelphiaGoogle Scholar
  82. Küry S, Kharfi M, Kamoun R et al (2003) Mutation spectrum of human SLC39A4 in a panel of patients with acrodermatitis enteropathica. Hum Mutat 22:337–338PubMedGoogle Scholar
  83. Lai JL, Preudhomme C, Zandecki M et al (1994) Myelodysplastic syndromes and acute myeloid leukemia with 17p deletion. An entity characterized by specific dysgranulopoïesis and a high incidence of P53 mutations. Leukemia 9:370–381Google Scholar
  84. Lee JY, Cole TB, Palmiter RD, Suh SW, Koh JY (2002) Contribution by synaptic zinc to the gender-disparate plaque formation in human Swedish mutant APP transgenic mice. Proc Natl Acad Sci USA 99:7705–7710PubMedGoogle Scholar
  85. Lee JY, Friedman JE, Angel I, Kozak A, Koh JY (2004) The lipophilic metal chelator DP-109 reduces amyloid pathology in brains of human beta-amyloid precursor protein transgenic mice. Neurobiol Aging 25:1315–1321PubMedGoogle Scholar
  86. Levy S, Beharier O, Etzion Y, Mor M, Buzaglo L, Shaltiel L et al (2009) Molecular basis for zinc transporter 1 action as an endogenous inhibitor of L-type calcium channels. J Biol Chem 284:32434–32443PubMedGoogle Scholar
  87. Lichten LA, Cousins RJ (2009) Mammalian zinc transporters: nutritional and physiologic regulation. Annu Rev Nutr 29:153–176PubMedGoogle Scholar
  88. Little PJ, Bhattacharya R, Moreyra AE, Korichneva IL (2010) Zinc and cardiovascular disease. Nutrition 26:1050–1057PubMedGoogle Scholar
  89. MacDonald RS (2000) The role of zinc in growth and cell proliferation. J Nutr 130:1500S–1508SPubMedGoogle Scholar
  90. Maret W (2003) Cellular zinc and redox states converge in the metallothionein/thionein pair. J Nutr 133(5 Suppl 1):S1460–S1462Google Scholar
  91. Maret W (2008) Metallothionein redox biology in the cytoprotective and cytotoxic functions of zinc. Exp Gerontol 43:363–369PubMedGoogle Scholar
  92. Margalioth EJ, Schenker JG, Chevion M (1983) Copper and zinc levels in normal and malignant tissues. Cancer Sci 52:868–872Google Scholar
  93. Maynard CJ, Bush AI, Masters CL, Cappai R, Li QX (2005) Metals and amyloid-beta in Alzheimer’s disease. Int J Exp Pathol 86:147–159PubMedGoogle Scholar
  94. Mocchegiani E, Fabris N (1995) Age-related thymus involution: zinc reverses in vitro the thymulin secretion effect. Int J Immunopharmacol 17:745–749PubMedGoogle Scholar
  95. Mocchegiani E, Muzzioli M (2000a) Zinc, metallothioneins, immune responses, survival and ageing. Biogerontology 1:133–143PubMedGoogle Scholar
  96. Mocchegiani E, Muzzioli M (2000b) Therapeutic application of zinc in human immunodeficiency virus against opportunistic infections. J Nutr 130(Suppl 5):S1424–S1431Google Scholar
  97. Mocchegiani E, Muzzioli M, Giacconi R (2000) Zinc and immunoresistance to infections in ageing: new biological tools. Trends Pharmacol Sci 21:205–208PubMedGoogle Scholar
  98. Mocchegiani E, Giacconi R, Cipriano C, Muzzioli M, Fattoretti P, Bertoni-Freddari C, Isani G, Zambenedetti P, Zatta P (2001) Zinc-bound metallothioneins as potential biological markers of ageing. Brain Res Bull 55:147–153PubMedGoogle Scholar
  99. Mocchegiani E, Giacconi R, Cipriano C, Gasparini N, Orlando F, Stecconi R, Muzzioli M, Isani G, Carpene E (2002) Metallothioneins (I+II) and thyroid-thymus axis efficiency in old mice: role of corticosterone and zinc supply. Mech Ageing Dev 123:675–694PubMedGoogle Scholar
  100. Mocchegiani E, Muzzioli M, Giacconi R, Cipriano C, Gasparini N, Franceschi C, Gaettic R, Cavalierid E, Suzukid H (2003) Metallothioneins/PARP-1/IL-6 interplay on natural killer cell activity in elderly: parallelism with nonagenarians and old infected humans. Effect of zinc supply. Mech Ageing Dev 124:459–468PubMedGoogle Scholar
  101. Mocchegiani E, Costarelli L, Giacconi R, Piacenza F, Basso A, Malavolta M. (2011) Zinc, metallothioneins and immunosenescence: effect of zinc supply as nutrigenomic approach. Biogerontology. [Epub ahead of print] PMID: 21503725Google Scholar
  102. Murakami M, Hirano T (2008) Intracellular zinc homeostasis and zinc signaling. Cancer Sci 99:1515–1522PubMedGoogle Scholar
  103. Muzzioli M, Stecconi R, Moresi R, Provinciali M (2009) Zinc improves the development of human CD34+ cell progenitors towards NK cells andincreases the expression of GATA-3 transcription factor in young and old ages. Biogerontology 10(5):593–604PubMedGoogle Scholar
  104. Nagano Y, Mavrakis KJ, Lee KL, Fujii T, Koinuma D, Sase H, Yuki K, Isogaya K, Saitoh M, Imamura T, Episkopou V, Miyazono K, Miyazawa K (2007) Arkadia induces degradation of SnoN and c-Ski to enhance transforming growth factor-beta signaling. J Biol Chem 282:20492–20501PubMedGoogle Scholar
  105. Nath R, Kumar D, Li T, Singal KP (2000) Metallothioneins, oxidative stress and the cardiovascular system. Toxicology 155:17–26PubMedGoogle Scholar
  106. Ninh NX, Maiter D, Verniers J, Lause P, Ketelslegers JM, Thissen JP (1998) Failure of exogenous IGF-I to restore normal growth in rats submitted to dietary zinc deprivation. J Endocrinol 159:211–217PubMedGoogle Scholar
  107. Nowak G, Siwek M, Dudek D, Ziêba A, Pilc A (2003) Effect of zinc supplementation on antidepressant therapy in unipolar depression: a preliminary placebo-controlled study. Pol J Pharmacol 55:1143–1147PubMedGoogle Scholar
  108. Nowak G, Szewczyk B, Pilc A (2005) Zinc and depression. An update. Pharmacol Rep 57:713–718PubMedGoogle Scholar
  109. Pagani A, Villarreal L, Capdevila M, Atrian S (2007) The saccharomyces cerevisiae Crs5 metallothionein metal-binding abilities and its role in the response to zinc overload. Mol Microbiol 1:256–269Google Scholar
  110. Palecek E, Brazdova M, Cernocka H, Vlk D, Brazda V, Vojtesek B (1999) Effect of transition metals on binding of p53 protein to supercoiled DNA and to consensus sequence in DNA fragments. Oncogene 18(24):3617–3625PubMedGoogle Scholar
  111. Pittenger C, Sanacora G, Krystal JH (2007) The NMDA receptor as a therapeutic target in major depressive disorder. CNS Neurol Disord Drug Targets 2:101–115Google Scholar
  112. Plum LM, Rink L, Haase H (2010) The essential toxin: impact of zinc on human health. Int J Environ Res Public Health 7:1342–1365PubMedGoogle Scholar
  113. Prasad AS (1998) Zinc in human health: an update. J Trace Elem Exp Med 11:63–87Google Scholar
  114. Prasad AS (2009) Zinc: role in immunity, oxidative stress and chronic inflammation. Curr Opinion Clin Nutr Metab Care 12:646–652Google Scholar
  115. Prasad AS, Beck FW, Bao B, Fitzgerald JT, Snell DC, Steinberg JD, Cardozo LJ (2007) Zinc supplementation decreases incidence of infections in the elderly: effect of zinc on generation of cytokines and oxidative stress. Am J Clin Nutr 85(3):837–844PubMedGoogle Scholar
  116. Puertollano MA, Puertollano E, de Cienfuegos GÁ, de Pablo MA (2011) Dietary antioxidants: immunity and host defense. Curr Top Med Chem 11(14):1752–1766PubMedGoogle Scholar
  117. Rahman K (2007) Studies on free radicals, antioxidants, and co-factors. Clin Interv Aging 2:219–236PubMedGoogle Scholar
  118. Rink L, Gabriel P (2000) Zinc and the immune system. Proc Nutr Soc 4:541–552Google Scholar
  119. Rutter GA (2010) Think zinc, new roles for zinc in the control of insulin secretion. Islets 2(1):49–50PubMedGoogle Scholar
  120. Sato M (1992) Biological antioxidant defense system and metallothionein. Jpn J Toxicol Environ Health 38:228–239Google Scholar
  121. SCF (2003) Opinion of the Scientific Committee on Food on the tolerable upper intake level of zinc. European CommissionGoogle Scholar
  122. Schlag P, Seeling W, Merkle P, Betzler M (1978) Changes of serum-zinc in breast cancer. Langenbecks Arch Chir 2:129–133Google Scholar
  123. Scully R, Livingston DM (2000) In search of the tumour-suppressor functions of BRCA1 and BRCA2. Nature 408:429–432PubMedGoogle Scholar
  124. Seve M, Chimienti F, Favier A (2002) Role of intracellular zinc in programmed cell death. Pathol Biol (Paris) 50:212–221 Sheikh et al. 2010Google Scholar
  125. Sheikh A, Shamsuzzaman S, Ahmad SM, Nasrin D, Nahar S, Alam MM, Al Tarique A, Begum YA, Qadri SS, Chowdhury MI, Saha A, Larson CP, Qadri F (2010) Zinc influences innate immune responses in children with enterotoxigenic Escherichia coli-induced diarrhea. J Nutr 140(5):1049–1056PubMedGoogle Scholar
  126. Shimizu N, Fujiwara J, Ohnishi S, Sato M, Kodama H, Kohsaka T, Inui A, Fujisawa T, Tamai H, Ida S, Itoh S, Ito M, Horiike N, Harada M, Yoshino M, Aoki T (2010) Effects of long-term zinc treatment in Japanese patients with Wilson disease: efficacy, stability, and copper metabolism. Transl Res 156(6):350–357PubMedGoogle Scholar
  127. Shokrzadeh M, Ghaemian A, Salehifar E, Aliakbari S, Saravi SS, Ebrahimi P (2009) Serum zinc and copper levels in ischemic cardiomyopathy. Biol Trace Elem Res 127:116–123PubMedGoogle Scholar
  128. Singh RB, Niaz MA, Rastogi SS, Bajaj S, Gaoli Z, Shoumin Z (1998) Current zinc intake and risk of diabetes and coronary artery disease and factors associated with insulin resistance in rural and urban populations of North India. J Am Coll Nutr 17:564–570PubMedGoogle Scholar
  129. Sladek R, Rocheleau G, Rung J et al (2007) A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 445:881–885PubMedGoogle Scholar
  130. Stefanidou M, Maravelias C (2004) Metallothioneins in toxicology. Curr Top Toxicol 1:161–167Google Scholar
  131. Stefanidou M, Maravelias C, Dona A, Spiliopoulou C (2006) Zinc: a multipurpose trace element. Arch Toxicol 80(1):1–9 ReviewPubMedGoogle Scholar
  132. Stoltenberg M, Bruhn M, Sondergaard C, Doering P, West MJ et al (2005) Immersion autometallographic tracing of zinc ions in Alzheimer beta-amyloid plaques. Histochem Cell Biol 123:605–611PubMedGoogle Scholar
  133. Szewczyk B, Poleszak E, Wlaź P, Wróbel A, Blicharska E, Cichy A, Dybała M, Siwek A, Pomierny-Chamioło L, Piotrowska A, Brański P, Pilc A, Nowak G (2009) The involvement of serotonergic system in the antidepressant effect of zinc in the forced swim test. Prog Neuropsychopharmacol Biol Psychiatry 33(2):323–329PubMedGoogle Scholar
  134. Takeda A (2000) Movement of zinc and its functional significance in the brain. Brain Res Bull 34:137–148Google Scholar
  135. Taniguchi M, Seino K, Nakayama T (2003) The NKT cell system: bridging innate and acquired immunity. Nat Immunol 4:1164–1165PubMedGoogle Scholar
  136. Tanzi RE, Bertram L (2005) Twenty years of the Alzheimer’s disease amyloid hypothesis: a genetic perspective. Cell 120:545–555PubMedGoogle Scholar
  137. Tapiero H, Tew KD (2003) Trace elements in human physiology and pathology: zinc and metallothioneins. Biomed Pharmacother 57:399–411PubMedGoogle Scholar
  138. Taylor KM (2008) A distinct role in breast cancer for two LIV-1 family zinc transporters. Biochem Soc Trans 36(Pt 6):1247–1251PubMedGoogle Scholar
  139. Taylor KM, Vichova P, Jordan N, Hiscox S, Hendley R, Nicholson RI (2008) ZIP7-mediated intracellular zinc transport contributes to aberrant growth factor signaling in antihormone-resistant breast cancer cells. Endocrinology 149:4912–4920PubMedGoogle Scholar
  140. Thornberry NA, Lazebnik Y (1998) Caspases: enemies within. Science 281:1312–1316PubMedGoogle Scholar
  141. Trasobares E, Corbaton A, Gonzalez-Estecha M, Lopez-Colon JL, Prats P, Olivan P et al (2007) Effects of angiotensin-converting enzyme inhibitors (ACE i) on zinc metabolism in patients with heart failure. J Trace Elem Med Biol 21:53–55PubMedGoogle Scholar
  142. Truong-Tran AQ, Carter J, Ruffin RE, Zalewski PD (2001) The role of zinc in caspase activation and apoptotic cell death. Biometals 14:315–330PubMedGoogle Scholar
  143. Truong-Tran AQ, Grosser D, Ruffin RE, Murgia C, Zalewski PD (2003) Apoptosis in the normal and inflamed airway epithelium: role of zinc in epithelial protection and procaspase-3 regulation. Biochem Pharmacol 66:1459–1468PubMedGoogle Scholar
  144. Vallee BL (1995) The function of metallothionein. Neurochem Int 27:23–33PubMedGoogle Scholar
  145. Vallee BL, Auld DS (1993) New perspective on zinc biochemistry: cocatalytic sites in multi-zinc enzymes. Biochemistry 32(26):6493–6500PubMedGoogle Scholar
  146. Vallee BL, Falchuk KH (1993) The biochemical basis of zinc physiology. Physiol Rev 73:79–118PubMedGoogle Scholar
  147. Vara H, Martinez B, Santos A, Colino A (2002) Thyroid hormone regulates neurotransmitter release in neonatal rat hippocampus. Neuroscience 110:19–28PubMedGoogle Scholar
  148. Vasak M, Hasler DW (2000) Metallothioneins: new functional and structural insights. Curr Opin Chem Biol 4:177–183PubMedGoogle Scholar
  149. Verhaegh GW, Parat MO, Richard MJ, Hainaut P (1998) Modulation of p53 protein conformation and DNA-binding activity by intracellular chelation of zinc. Mol Carcinog 21:205–214PubMedGoogle Scholar
  150. Vogelstein B, Lane D, Levine AJ (2000) Surfing the p53 network. Nature 408:307–310PubMedGoogle Scholar
  151. Walker CL, Black RE (2010) Zinc for the treatment of diarrhoea: effect on diarrhoea morbidity, mortality and incidence of future episodes. Int J Epidemiol 39(Suppl 1):63–69Google Scholar
  152. Wang K, Zhou B, Kuo YM, Zemansky J, Gitschier J (2002) A novel member of a zinc transporter family is defective in acrodermatitis enteropathica. Am J Hum Genet 71:66–73PubMedGoogle Scholar
  153. Wang CY, Wang T, Zheng W, Zhao BL, Danscher G, Chen Y, Wang Z (2010) Zinc overload enhances APP cleavage and Ab deposition in the Alzheimer mouse brain. PLoS One 5(12):e15349PubMedGoogle Scholar
  154. Weiss JH, Sensi SL, Koh JY (2000) Zinc(2+): a novel ionic mediator of neural injury in brain disease. Trends Pharmacol Sci 21:395–401PubMedGoogle Scholar
  155. Wellinghausen N, Rink L (1998) The significance of zinc for leukocyte biology. J Leukoc Biol 64:571–577PubMedGoogle Scholar
  156. Wellinghausen N, Martin M, Rink L (1997) Zinc inhibits interleukin-1- dependent T cell stimulation. Eur J Immunol 27:2529–2535PubMedGoogle Scholar
  157. Whittle N, Lubec G, Singewald N (2009) Zinc deficiency induces enhanced depression-like behaviour and altered limbic activation reversed by antidepressant treatment in mice. Amino Acids 36(1):147–158PubMedGoogle Scholar
  158. Witte KK, Clark AL, Cleland JG (2001) Chronic heart failure and micronutrients. J Am Coll Cardiol 37:1765–1774PubMedGoogle Scholar
  159. Wong SH, Zhao Y, Schoene NW, Han CT, Shih RS, Lei KY (2007) Zinc deficiency depresses p21 gene expression: inhibition of cell cycle progression is independent of the decrease in p21 protein level in HepG2 cells. Am J Physiol Cell Physiol 292:C2175–C2184PubMedGoogle Scholar
  160. Wu LC, Wang ZW, Tsan JT, Spillman MA, Phung A, Xu XL et al (1996) Identification of a RING protein that can interact in vivo with the BRCA1 gene product. Nat Genet 14:430–440PubMedGoogle Scholar
  161. Xia Y, Pao GM, Chen HW, Verma IM, Hunter T (2003) Enhancement of BRCA1 E3 ubiquitin ligase activity through direct interaction with the BARD1 protein. J Biol Chem 278:5255–5263PubMedGoogle Scholar
  162. Yamasaki S, Sakata-Sogawa K, Hasegawa A, Suzuki T, Kabu K, Sato E, Kurosaki T, Yamashita S, Tokunaga M, Nishida K, Hirano T (2007) Zinc is a novel intracellular second messenger. J Cell Biol 177:637–645PubMedGoogle Scholar
  163. Yary T, Aazami S (2011) Dietary intake of zinc was inversely associated with depression. Biol Trace Elem Res. [Epub ahead of print] PMID:21932045Google Scholar
  164. Zhang R, Wang H (2000) MDM2 oncogene as a novel target for human cancer therapy. Curr Pharm Des 6:393–416Google Scholar
  165. Zhang LH, Wang X, Zheng ZH, Ren H, Stoltenberg M et al (2010) Altered expression and distribution of zinc transporters in APP/PS1 transgenic mouse brain. Neurobiol Aging 31:74–87PubMedGoogle Scholar
  166. Zhao XQ, Bai FW (2011) Zinc and yeast stress tolerance: micronutrient plays a big role. J Biotechnol. [Epub ahead of print] PMID:21763361Google Scholar
  167. Zhao H, Eide D (1996) The yeast ZRT1 gene encodes the zinc transporter protein of a high-affinity uptake system induced by zinc limitation. Proc Natl Acad Sci USA 93:2454–2458PubMedGoogle Scholar
  168. Zheng W, Xin N, Chi ZH, Zhao BL, Zhang J et al (2009) Divalent metal transporter 1 is involved in amyloid precursor protein processing and Abeta generation. FASEB J 23:4207–4217PubMedGoogle Scholar
  169. Zheng W, Wang T, Yu D, Feng WY, Nie YX et al (2010) Elevation of zinc transporter ZnT3 protein in the cerebellar cortex of the AbetaPP/PS1 transgenic mouse. J Alzheimers Dis 20:323–331PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • Christos T. Chasapis
    • 1
  • Ariadni C. Loutsidou
    • 1
  • Chara A. Spiliopoulou
    • 2
  • Maria E. Stefanidou
    • 2
  1. 1.Department of Pharmacy, School of Health SciencesUniversity of PatrasPatrasGreece
  2. 2.Department of Forensic Medicine and Toxicology, School of MedicineUniversity of AthensGoudi, AthensGreece

Personalised recommendations